Sionna Therapeutics Statistics
NASDAQ: SIONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.82+0.07 (+1.47%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Sionna Therapeutics by the numbers
Sionna Therapeutics has a market capitalization of $217.6 million based on 45.15M shares outstanding. With trailing EPS of $-2.16, Sionna Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 64.7% below its 50-day average and 85.6% below its 200-day average.
Average daily trading volume is 2.18M shares, or about $10.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SION valuation vs. peer median
| Metric | SION | Peer median | Difference |
|---|---|---|---|
| Market cap | $217.62M | $221.90M | -2% |
| Avg. volume | 2.18M | 179.06K | +1118% |
Peer median across 8 companies: TRDA, LYEL, NATR, KROS, EVMN, GLSI, MGNX, RNAC.
Valuation
- Market cap
- $217.62M
- EPS (TTM)
- $-2.16
- Shares outstanding
- 45.15M
Price and trading
- Previous close
- 4.75
- Open
- 4.68
- Day range
- 4.61 – 4.86
- 52-week range
- 4.01 – 54.97
- 52-week change
- -83.15%
- Beta
- —
- Volume
- 879.93K
- Average volume
- 2.18M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 217.62M
- Forward Pe
- -2.16
- Eps
- -2.16
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 54.97
- Week52 Low
- 4.01
- Avg Volume
- 2.18M
- Shares Outstanding
- 45.15M
- Ma50
- 13.65
- Ma200
- 33.41
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -91.23%
- Pct From52w Low
- 20.20%